{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T01:44:44Z","timestamp":1768700684786,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":4329,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1093\/annonc\/mdm463","type":"journal-article","created":{"date-parts":[[2007,9,30]],"date-time":"2007-09-30T00:13:25Z","timestamp":1191111205000},"page":"247-253","source":"Crossref","is-referenced-by-count":90,"title":["A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma"],"prefix":"10.1016","volume":"19","author":[{"given":"F.","family":"Morschhauser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.C.","family":"Kluin-Nelemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pfreundschuh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Tilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Raemaekers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.B.","family":"van \u2019t Veer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Milpied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Cartron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pezzutto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dreyling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdm463_bb0010","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Study Group classification of non-Hodgkin\u2019s lymphoma","volume":"89","author":"The Non-Hodgkin\u2019s Lymphoma Classification Project","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdm463_bb0015","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1200\/JCO.1996.14.4.1269","article-title":"Mantle-cell lymphoma: a population-based clinical study","volume":"14","author":"Velders","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm463_bb0020","first-page":"93","article-title":"Mantle cell lymphomas","volume":"84","author":"Hiddemann","year":"1999","journal-title":"Haematologica"},{"key":"10.1093\/annonc\/mdm463_bb0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/oxfordjournals.annonc.a059155","article-title":"Patterns of survival in mantle cell lymphoma","volume":"6","author":"Zucca","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdm463_bb0030","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1200\/JCO.2005.55.017","article-title":"Current treatment approaches for mantle-cell lymphoma","volume":"23","author":"Witzig","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm463_bb0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00277-003-0774-2","article-title":"Mantle cell lymphoma: established therapeutic options and future directions","volume":"83","author":"Lenz","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1093\/annonc\/mdm463_bb0040","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1200\/JCO.1998.16.5.1922","article-title":"Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group","volume":"16","author":"Hiddemann","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm463_bb0045","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2004-04-1323","volume":"104","author":"Forstpointner","year":"2004","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdm463_bb0050","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1200\/JCO.20.5.1288","article-title":"Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival","volume":"20","author":"Howard","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm463_bb0055","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1200\/JCO.2005.08.133","volume":"23","author":"Lenz","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm463_bb0060","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00001622-200109000-00005","article-title":"Biology and management of mantle cell lymphoma","volume":"13","author":"Leonard","year":"2001","journal-title":"Curr Opin Oncol"},{"key":"10.1093\/annonc\/mdm463_bb0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1615\/CritRevImmunol.v17.i3-4.50","article-title":"Biochemistry of antigen receptor signaling in mature and developing B lymphocytes","volume":"17","author":"Bireland","year":"1997","journal-title":"Crit Rev Immunol"},{"key":"10.1093\/annonc\/mdm463_bb0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/mi.2.3.141","article-title":"Emerging roles for PKC isoforms in immune cell function","volume":"2","author":"Su","year":"2002","journal-title":"Mol Interv"},{"key":"10.1093\/annonc\/mdm463_bb0075","first-page":"2655","article-title":"Antigen receptor-induced signal transduction imbalances associated with the negative selection of immature B cells","volume":"162","author":"King","year":"1999","journal-title":"J Immunol"},{"key":"10.1093\/annonc\/mdm463_bb0080","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/ni823","article-title":"PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling","volume":"3","author":"Su","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1093\/annonc\/mdm463_bb0085","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1084\/jem.20020408","article-title":"Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha","volume":"195","author":"Saijo","year":"2002","journal-title":"J Exp Med"},{"key":"10.1093\/annonc\/mdm463_bb0090","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1084\/jem.20051591","article-title":"PKC beta regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1","volume":"202","author":"Shinohara","year":"2005","journal-title":"J Exp Med"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdm463_bb0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/theoncologist.5-suppl_1-3","article-title":"VEGF receptor signaling in tumor angiogenesis","volume":"5","author":"McMahon","year":"2000","journal-title":"Oncologist"},{"key":"10.1093\/annonc\/mdm463_bb0100","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.leukres.2003.11.002","article-title":"Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin\u2019s lymphoma or Hodgkin\u2019s lymphoma","volume":"28","author":"Giles","year":"2004","journal-title":"Leuk Res"},{"key":"10.1093\/annonc\/mdm463_bb0105","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1046\/j.1365-2141.1999.01547.x","article-title":"Angiogenic growth factors and endostatin in non-Hodgkin\u2019s lymphoma","volume":"106","author":"Bertolini","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdm463_bb0110","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nm0102-68","article-title":"Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning","volume":"8","author":"Shipp","year":"2002","journal-title":"Nat Med"},{"key":"10.1093\/annonc\/mdm463_bb0115","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/modpathol.3800434","article-title":"Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma","volume":"18","author":"Hans","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1093\/annonc\/mdm463_bb0120","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2559.2007.02666.x","article-title":"Heterogeneity of protein kinase C beta(2) expression in lymphoid malignancies","volume":"50","author":"Decouvelaere","year":"2007","journal-title":"Histopathology"},{"key":"10.1093\/annonc\/mdm463_bb0125","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0960-894X(03)00286-5","article-title":"Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCbeta","volume":"13","author":"Faul","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1093\/annonc\/mdm463_bb0130","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1158\/0008-5472.CAN-05-0071","article-title":"The protein kinase Cbeta-selective inhibitor, enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts","volume":"65","author":"Graff","year":"2005","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdm463_bb0135","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2005.05630.x","article-title":"Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways","volume":"130","author":"Rizzatti","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdm463_bb0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1582-4934.2005.tb00337.x","article-title":"The activation of Akt\/PKB signaling pathway and cell survival","volume":"9","author":"Song","year":"2005","journal-title":"J Cell Mol Med"},{"key":"10.1093\/annonc\/mdm463_bb0145","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predict survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1093\/annonc\/mdm463_bb0150","first-page":"8226","article-title":"The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival","volume":"63","author":"Martinez","year":"2003","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdm463_bb0155","article-title":"PKCbeta: a rational therapeutic target in diffuse large B-cell lymphoma","volume":"100","author":"Wu","year":"2002","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdm463_bb0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00280-001-0386-2","article-title":"Antiangiogenic effects of a protein kinase Cbeta-selective small molecule","volume":"49","author":"Teicher","year":"2002","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1093\/annonc\/mdm463_bb0165","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1200\/JCO.2005.05.3447","article-title":"Phase I dose escalation and pharmacokinetic study of enzastaurin, an oral protein kinase C beta inhibitor, in patients with advanced cancer","volume":"24","author":"Carducci","year":"2006","journal-title":"J Clin Oncol"},{"issue":"Suppl 18S","key":"10.1093\/annonc\/mdm463_bb0170","article-title":"Phase I and pharmacokinetic evaluation of enzastaurin combined with gemcitabine and cisplatin in advanced cancer","volume":"24","author":"Beerepoot","year":"2006","journal-title":"J Clin Oncol"},{"issue":"Suppl 18S","key":"10.1093\/annonc\/mdm463_bb0175","article-title":"A phase I dose-escalation and pharmacokinetic study of enzastaurin combined with capecitabine in patients with advanced cancer","volume":"24","author":"Leong","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm463_bb0180","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1200\/JCO.2006.09.3146","article-title":"Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma","volume":"25","author":"Robertson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm463_bb0185","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm463_bb0190","author":"National Cancer Institute","year":"1998","journal-title":"Cancer Therapy Evaluation Program Common Toxicity Criteria v2.0 (CTC)"},{"key":"10.1093\/annonc\/mdm463_bb0195","unstructured":"Wang MY, Acosta K, Theiss N. Development of an automated immunohistochemistry assay to detect protein kinase C-bII and its application to breast cancer. Presented at The Tucson Symposium, Tucson, AZ, 6\u20137 March 2007 (Abstr 7645)."},{"key":"10.1093\/annonc\/mdm463_bb0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2125.2006.02713.x","article-title":"Drug development in oncology: classical cytotoxics and molecularly targeted agents","volume":"62","author":"Kummar","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1093\/annonc\/mdm463_bb0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2141.2005.05716.x","article-title":"Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network","volume":"131","author":"Tiemann","year":"2005","journal-title":"Br J Haematol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341941332X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341941332X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/19\/2\/247\/723405\/mdm463.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T13:22:06Z","timestamp":1582204926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341941332X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S092375341941332X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdm463","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}